Use of artesunate in the treatment of severe imported malaria in France: review of the effectiveness and real-life safety in two French university hospitals

BACKGROUND: Intravenous artesunate (AS) is the first-line treatment for patients with severe imported malaria (SIM) worldwide. However, after 10 years of use in France, AS hasn’t yet received marketing authorization.The purpose of this study was to assess the real-life effectiveness and safety of AS...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonsergent, M., Tching-Sin, M., Honoré, S., Bertault-Peres, P., Lepelletier, A., Flet, L., Perez, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214604/
https://www.ncbi.nlm.nih.gov/pubmed/37231336
http://dx.doi.org/10.1186/s12879-023-08260-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10214604/
https://www.ncbi.nlm.nih.gov/pubmed/37231336
http://dx.doi.org/10.1186/s12879-023-08260-6

Ejemplares similares